Myos Corporation (MYOS) Reports Data Showing Fortetropin's Anti-Inflammatory …

Myos Corporation (MYOS) Reports Data Showing Fortetropin's Anti-Inflammatory …

Further analysis of serum biomarkers from subjects in the clinical trial revealed that daily use of Fortetropin significantly decreases inflammatory cytokine levels which demonstrates Fortetropin's promising anti-inflammatory biotherapeutic properties.

(Visited 1 times, 1 visits today)
12
Like
Save

Comments

Comments are disabled for this post.